Titre : Études transversales

Études transversales : Questions médicales fréquentes

Termes MeSH sélectionnés :

Practice Patterns, Physicians'
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Études transversales : Questions médicales les plus fréquentes", "headline": "Études transversales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Études transversales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-12", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Études transversales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Études épidémiologiques", "url": "https://questionsmedicales.fr/mesh/D016021", "about": { "@type": "MedicalCondition", "name": "Études épidémiologiques", "code": { "@type": "MedicalCode", "code": "D016021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500" } } }, "about": { "@type": "MedicalCondition", "name": "Études transversales", "alternateName": "Cross-Sectional Studies", "code": { "@type": "MedicalCode", "code": "D003430", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andreea Teodora Constantin", "url": "https://questionsmedicales.fr/author/Andreea%20Teodora%20Constantin", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine, University of Medicine and Pharmacy \"Carol Davila\", 020021 Bucharest, Romania." } }, { "@type": "Person", "name": "Ioana Rosca", "url": "https://questionsmedicales.fr/author/Ioana%20Rosca", "affiliation": { "@type": "Organization", "name": "Faculty of Midwifery and Nursery, University of Medicine and Pharmacy \"Carol Davila\", 020021 Bucharest, Romania." } }, { "@type": "Person", "name": "Mandana Hoseini", "url": "https://questionsmedicales.fr/author/Mandana%20Hoseini", "affiliation": { "@type": "Organization", "name": "PhD graduate, Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran." } }, { "@type": "Person", "name": "Fateme Jalousian", "url": "https://questionsmedicales.fr/author/Fateme%20Jalousian", "affiliation": { "@type": "Organization", "name": "Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran." } }, { "@type": "Person", "name": "Seyed Hosein Hoseini", "url": "https://questionsmedicales.fr/author/Seyed%20Hosein%20Hoseini", "affiliation": { "@type": "Organization", "name": "Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Value-Based Care for Chest Physicians.", "datePublished": "2023-01-07", "url": "https://questionsmedicales.fr/article/36627080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chest.2022.12.041" } }, { "@type": "ScholarlyArticle", "name": "Current clinical practice and physicians' insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation.", "datePublished": "2024-08-23", "url": "https://questionsmedicales.fr/article/39179992", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12797-3" } }, { "@type": "ScholarlyArticle", "name": "Comparison of Work Patterns Between Physicians and Advanced Practice Practitioners in Primary Care and Specialty Practice Settings.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37310739", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.18061" } }, { "@type": "ScholarlyArticle", "name": "Impact of educational training and C-reactive protein point-of-care testing on antibiotic prescribing in rural and urban family physician practices in Latvia: a randomised controlled intervention study.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36127630", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-022-03608-4" } }, { "@type": "ScholarlyArticle", "name": "Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/36866850", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICU.0000000000000944" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Caractéristiques des études épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D016020" }, { "@type": "ListItem", "position": 6, "name": "Études épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D016021" }, { "@type": "ListItem", "position": 7, "name": "Études transversales", "item": "https://questionsmedicales.fr/mesh/D003430" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Études transversales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Études transversales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Études transversales", "description": "Comment les études transversales aident-elles au diagnostic ?\nPeut-on établir un diagnostic définitif avec une étude transversale ?\nQuel type de données recueille une étude transversale ?\nLes études transversales peuvent-elles identifier des biomarqueurs ?\nQuel est l'avantage principal des études transversales pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Études transversales", "description": "Les études transversales identifient-elles des symptômes ?\nPeut-on relier des symptômes à des facteurs de risque via ces études ?\nComment les symptômes sont-ils mesurés dans ces études ?\nLes études transversales peuvent-elles révéler des symptômes rares ?\nLes symptômes peuvent-ils varier selon les groupes d'âge dans ces études ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Études transversales", "description": "Les études transversales aident-elles à identifier des stratégies de prévention ?\nPeut-on évaluer l'impact des programmes de prévention avec ces études ?\nComment les comportements préventifs sont-ils mesurés ?\nLes études transversales peuvent-elles identifier des populations à risque ?\nLes résultats des études transversales influencent-ils les politiques de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Études transversales", "description": "Les études transversales évaluent-elles l'efficacité des traitements ?\nPeut-on observer des tendances de traitement dans ces études ?\nLes études transversales peuvent-elles influencer les pratiques de traitement ?\nComment les traitements sont-ils documentés dans ces études ?\nLes études transversales peuvent-elles révéler des inégalités dans l'accès aux traitements ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Études transversales", "description": "Les études transversales peuvent-elles identifier des complications associées ?\nComment les complications sont-elles documentées dans ces études ?\nPeut-on évaluer la gravité des complications avec ces études ?\nLes études transversales peuvent-elles révéler des complications rares ?\nLes complications peuvent-elles varier selon les groupes démographiques ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Études transversales", "description": "Les études transversales identifient-elles des facteurs de risque ?\nPeut-on établir une causalité avec des études transversales ?\nComment les facteurs de risque sont-ils mesurés ?\nLes études transversales peuvent-elles révéler des facteurs de risque émergents ?\nLes facteurs de risque varient-ils selon les populations étudiées ?", "url": "https://questionsmedicales.fr/mesh/D003430?mesh_terms=Practice+Patterns,+Physicians'&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les études transversales aident-elles au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer la prévalence des maladies et d'identifier des associations." } }, { "@type": "Question", "name": "Peut-on établir un diagnostic définitif avec une étude transversale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles fournissent des données descriptives mais ne permettent pas de causalité." } }, { "@type": "Question", "name": "Quel type de données recueille une étude transversale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des données sur la santé, les comportements et les caractéristiques démographiques." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles identifier des biomarqueurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent suggérer des biomarqueurs associés à des conditions, mais pas prouver leur causalité." } }, { "@type": "Question", "name": "Quel est l'avantage principal des études transversales pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent une évaluation rapide et peu coûteuse de la santé d'une population." } }, { "@type": "Question", "name": "Les études transversales identifient-elles des symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent décrire la prévalence des symptômes dans une population donnée." } }, { "@type": "Question", "name": "Peut-on relier des symptômes à des facteurs de risque via ces études ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent montrer des associations, mais ne prouvent pas de relations causales." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils mesurés dans ces études ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Par des questionnaires, des entretiens ou des examens cliniques standardisés." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles révéler des symptômes rares ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont moins efficaces pour les symptômes rares en raison de la taille de l'échantillon." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon les groupes d'âge dans ces études ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les études peuvent montrer des variations de symptômes selon les tranches d'âge." } }, { "@type": "Question", "name": "Les études transversales aident-elles à identifier des stratégies de prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent suggérer des facteurs de risque à cibler pour des interventions préventives." } }, { "@type": "Question", "name": "Peut-on évaluer l'impact des programmes de prévention avec ces études ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne mesurent que la prévalence avant l'implémentation des programmes." } }, { "@type": "Question", "name": "Comment les comportements préventifs sont-ils mesurés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Par des questionnaires sur les habitudes de vie et les comportements de santé." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles identifier des populations à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent révéler des groupes à risque élevé pour cibler les efforts de prévention." } }, { "@type": "Question", "name": "Les résultats des études transversales influencent-ils les politiques de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des données essentielles pour orienter les politiques de santé publique." } }, { "@type": "Question", "name": "Les études transversales évaluent-elles l'efficacité des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne mesurent que la prévalence des traitements, pas leur efficacité." } }, { "@type": "Question", "name": "Peut-on observer des tendances de traitement dans ces études ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent montrer des tendances dans l'utilisation des traitements au sein d'une population." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles influencer les pratiques de traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent fournir des données qui orientent les décisions cliniques et les politiques de santé." } }, { "@type": "Question", "name": "Comment les traitements sont-ils documentés dans ces études ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes sur les antécédents médicaux et les traitements en cours des participants." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles révéler des inégalités dans l'accès aux traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent mettre en lumière des disparités dans l'accès aux soins et aux traitements." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles identifier des complications associées ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent montrer des associations entre maladies et complications, mais pas de causalité." } }, { "@type": "Question", "name": "Comment les complications sont-elles documentées dans ces études ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Par des rapports de cas, des questionnaires et des examens cliniques des participants." } }, { "@type": "Question", "name": "Peut-on évaluer la gravité des complications avec ces études ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne mesurent que la prévalence, pas la gravité ou l'évolution des complications." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles révéler des complications rares ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont moins efficaces pour identifier des complications rares en raison de la taille de l'échantillon." } }, { "@type": "Question", "name": "Les complications peuvent-elles varier selon les groupes démographiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les études peuvent montrer des variations de complications selon l'âge, le sexe, etc." } }, { "@type": "Question", "name": "Les études transversales identifient-elles des facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent révéler des associations entre facteurs de risque et maladies." } }, { "@type": "Question", "name": "Peut-on établir une causalité avec des études transversales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles montrent des associations mais ne peuvent pas prouver la causalité." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils mesurés ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Par des questionnaires, des entretiens et des données cliniques des participants." } }, { "@type": "Question", "name": "Les études transversales peuvent-elles révéler des facteurs de risque émergents ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent identifier de nouveaux facteurs de risque à étudier plus en profondeur." } }, { "@type": "Question", "name": "Les facteurs de risque varient-ils selon les populations étudiées ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les études peuvent montrer des variations de facteurs de risque selon les groupes." } } ] } ] }

Sources (10000 au total)

Current clinical practice and physicians' insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation.

The present study aimed to investigate physicians' perspectives on the diagnosis and treatment decisions for patients with non-small cell lung cancer (NSCLC) harbouring epidermal growth factor recepto... This study was performed via the CAPTRA-Lung collaboration between December 9, 2022 and March 6, 2023. The questionnaire was distributed digitally to physicians around China and was comprised of three... A total of 53,729 questionnaires were distributed and 390 valid ones were collected. The EGFR mutation test was performed in 80.9% and 59.9% of patients receiving first-line or second-line therapy and... This study investigated the current diagnosis and treatment status and physicians' perspective, of patients with EGFR exon20ins-mutant NSCLC. The results highlight significant unmet clinical needs in ...

Comparison of Work Patterns Between Physicians and Advanced Practice Practitioners in Primary Care and Specialty Practice Settings.

Despite the increasing involvement of advanced practice practitioners (APPs; ie, nurse practitioners and physician assistants) in care delivery across specialties, the work patterns of APPs compared w... To characterize differences between physicians and APPs across specialty types related to days with appointments, visit types seen, and time spent using the electronic health record (EHR).... This nationwide, cross-sectional study used EHR data from physicians and APPs (ie, nurse practitioners and physician assistants) at all US institutions that used Epic Systems' EHR between January and ... Appointment scheduling patterns, percentage of new and established and level of evaluation and management (E/M) visits, and EHR use metrics per day and week.... The sample consisted of 217 924 clinicians across 389 organizations, including 174 939 physicians and 42 985 APPs. Although primary care physicians were more likely than APPs to have more than 3 days ... This cross-sectional, national study of clinicians found significant differences in visit and EHR patterns for physicians compared with APPs across specialty types. By underscoring the different curre...

Impact of educational training and C-reactive protein point-of-care testing on antibiotic prescribing in rural and urban family physician practices in Latvia: a randomised controlled intervention study.

Although self-limiting viral infections are predominant, children with acute infections are often prescribed antibiotics by family physicians. The aim of the study is to evaluate the impact of two int... This randomised controlled intervention study included acutely ill children consulted by 80 family physicians from urban and rural practices in Latvia. The family physicians were divided into two grou... In total, 2039 children with acute infections were enrolled in the study. The most common infections observed were upper and lower respiratory tract infections. Overall, 29.8% (n = 607) of the study p... Our results show that the availabilty of C-reactive protein point-of-care testing and educational training for family physicians did not reduce antibiotic prescribing. Nevertheless, our data indicate ...

Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study.

Clinical trial publications may influence physician prescribing patterns. The Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol T study, published in 2015, examined outcomes of intrav... Anti-VEGF agents have revolutionized treatment of DME by blocking angiogenesis signalled by VEGF. Three commonly used anti-VEGF agents are on-label aflibercept (Eylea, Regeneron) and ranibizumab (Luce... From 2013 to 2018, there was a significant positive trend in the average number of aflibercept injections for any indication ( P < 0.002). There was no significant trend in the average number of bevac...

Physician Reluctance to Intervene in Addiction: A Systematic Review.

The overdose epidemic continues in the US, with 107 941 overdose deaths in 2022 and countless lives affected by the addiction crisis. Although widespread efforts to train and support physicians to imp... To describe physician-reported reasons for reluctance to address substance use and addiction in their clinical practices using screening, treatment, harm reduction, or recovery support interventions.... A literature search of PubMed, Embase, Scopus, medRxiv, and SSRN Medical Research Network was conducted and returned articles published from January 1, 1960, through October 5, 2021.... Publications that included physicians, discussed substance use interventions, and presented data on reasons for reluctance to intervene in addiction were included.... Two reviewers (L.N., M.C., L.F., J.P., C.S., and S.W.) independently reviewed each publication; a third reviewer resolved discordant votes (M.C. and W.C.). This systematic review was conducted accordi... The primary outcome was reasons for physician reluctance to address substance use disorder. The association of reasons for reluctance with practice setting and drug type was also measured. Reasons and... A total of 183 of 9308 returned studies reporting data collected from 66 732 physicians were included. Most studies reported survey data. Alcohol, nicotine, and opioids were the most often studied sub... In this systematic review of reasons for physician reluctance to intervene in addiction, the most common reasons were lack of institutional support, knowledge, skill, and cognitive capacity. Targeting...

Chronic tracheostomy care of ventilator-dependent and -independent children: Clinical practice patterns of pediatric respirologists in a publicly funded (Canadian) healthcare system.

To describe the current clinical practice patterns of Canadian pediatric respirologists at pediatric tertiary care institutions regarding chronic tracheostomy tube care and management of home invasive... A pediatric respirologist/pediatrician with expertise in tracheostomy tube care and home ventilation was identified at each Canadian pediatric tertiary care center to complete a 59-item survey of mult... The response rate was 100% (17/17) with all Canadian tertiary care pediatric centers represented and heterogeneity of practice was observed in all domains assessed. For example, though most centers em... Considerable variability in pediatric tracheostomy tube care practice exists across Canada. These results will serve as a starting point to standardize and evaluate tracheostomy tube care nationally....

Management of the smaller twin with impending compromise in twin pregnancies complicated by selective fetal growth restriction: a questionnaire-based study of clinical practice patterns.

In twin pregnancies complicated by selective fetal growth restriction (sFGR), if the smaller twin is in the state of impending intra-uterine death (IUD), immediate delivery will reduce the risk of IUD... An online cross-sectional survey was performed with obstetricians and gynecologists (OBGYN) in South Korea. The questionnaire asked the following: (1) whether participants would maintain or immediatel... A total of 156 OBGYN answered the questionnaires. In a clinical scenario of dichorionic (DC) twin pregnancy complicated by sFGR with signs of impending IUD of the smaller twin, 57.1% of the participan... Participants preferred to immediately deliver twin pregnancies complicated by sFGR with impending IUD of the smaller twin at the limit of intact survival (30 weeks) for DC twin pregnancies and at the ...

Knowledge, Attitudes, and Practice Patterns of Lung Cancer Screening Among Physicians in Saudi Arabia.

Lung cancer remains the primary cause of death connected to cancer on a worldwide scale. Obtaining a deep understanding of the knowledge, attitudes, and behavior patterns of doctors is essential for d... An online survey was conducted from July to December 2023 to investigate the attitudes, beliefs, referral practices, and knowledge of lung cancer screening, and adherence to lung cancer screening reco... This study involved a total of 96 physicians. The study participants demonstrated a significant degree of understanding regarding lung cancer screening, with an average knowledge score of 5.8 (SD: 1.7... The study's results indicate that there is a need for the development of specialized educational initiatives aimed at Saudi Arabian physicians, particularly those with 11 to 15 years of experience who...